Lisa Klenke, RN, CEO of Coldwater, Ohio-based Mercer Health, will retire June 30 after 12 years in the role.
Category: Channels
How HCA, Tenet, CHS and UHS stacked up in 2024
Three of the four largest publicly traded for-profit hospital operators reported increases in their net income in 2024.
1st death confirmed in measles outbreak: 4 updates
An unvaccinated school-age child in Texas became the first known U.S. measles fatality since 2015, The Washington Post reported Feb. 26.
MUSC Health regional division taps COO
Rick Hundorfean was appointed COO of the MUSC Health-Charleston Division in South Carolina.
California system chief nursing officer heads to UNC Health
Kinston, N.C.-based UNC Health Lenoir welcomed Keri Noeske, DNP, RN, as chief nursing officer and vice president, Neuse News reported Feb. 26.
California system chief nursing officer heads to UNC Health
Kinston, N.C.-based UNC Health Lenoir welcomed Keri Noeske, DNP, RN, as chief nursing officer and vice president, Neuse News reported Feb. 26.
Maine hospital names president
Ava Collins was appointed president of Northern Light Eastern Maine Medical Center in Bangor, according to a Feb. 26 news release shared with Becker’s.
Hospitals and healthcare professionals must lead on firearm injury prevention to keep children and communities safe
Firearm-related injuries have been the leading cause of death for children and teens in the United States since 2022, killing more children than car crashes, cancer or infectious illnesses. Yet, we don’t approach firearm injury prevention with the same…
Compounding pharmacies sue over semaglutide removal from shortage lis
A group of compounding pharmacies has filed a lawsuit against the FDA, challenging the agency’s decision to remove semaglutide — which is used to treat Type 2 diabetes and obesity — from the drug shortage list.
Breast cancer drug shows positive results in late-stage trial
AstraZeneca’s experimental breast cancer drug camizestrant, when combined with a cyclin-dependent kinase inhibitor, has shown significant improvement in delaying disease progression in patients with hormone receptor-positive, HER2-negative advanced bre…
